About us
Ingenix.Ai Ltd specializes in developing a Biological Reasoning Engine that combines artificial intelligence with computational biology to enhance research and development decisions affecting clinical efficacy and safety. Their innovative approach, called Modality Fusion, synthesizes diverse biological data across various scales, facilitating mechanistic reasoning and evidence-based insights. The company works with pharmaceutical and biotech teams through their Qualified Access Program to address complex translational and clinical questions. Their mission is to increase the success rates of clinical trials and accelerate the development of effective therapies by enabling AI to truly understand biology. Operating at the intersection of AI and life sciences, Ingenix.Ai Ltd aims to transform drug development and personalized medicine.
Open positions